BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34292263)

  • 1. The Analysis of Hospital Readmission Rates After the Implementation of Hospital Readmissions Reduction Program.
    Muchiri S; Azadeh-Fard N; Pakdil F
    J Patient Saf; 2022 Apr; 18(3):237-244. PubMed ID: 34292263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program.
    Lu CH; Clark CM; Tober R; Allen M; Gibson W; Bednarczyk EM; Daly CJ; Jacobs DM
    BMC Health Serv Res; 2021 Apr; 21(1):386. PubMed ID: 33902569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.
    Rosenblatt R; Cohen-Mekelburg S; Shen N; Tafesh Z; Lucero C; Kumar S; Fortune B; Liu SY; Brown R; Jesudian A
    Am J Gastroenterol; 2019 Sep; 114(9):1488-1495. PubMed ID: 31180921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.
    Buhr RG; Jackson NJ; Kominski GF; Dubinett SM; Mangione CM; Ong MK
    J Gen Intern Med; 2020 Dec; 35(12):3581-3590. PubMed ID: 32556878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Effects of the Hospital Readmissions Reduction Program on Hospitals That Serve Poorer Patients.
    Wasfy JH; Bhambhani V; Healy EW; Choirat C; Dominici F; Wadhera RK; Shen C; Wang Y; Yeh RW
    Med Care; 2019 Dec; 57(12):968-976. PubMed ID: 31567860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Financial Incentives in Medicare's Hospital Readmissions Reduction Program and Hospital Readmission Performance.
    Hoffman GJ; Yakusheva O
    JAMA Netw Open; 2020 Apr; 3(4):e202044. PubMed ID: 32242906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.
    Ferro EG; Secemsky EA; Wadhera RK; Choi E; Strom JB; Wasfy JH; Wang Y; Shen C; Yeh RW
    Health Aff (Millwood); 2019 Apr; 38(4):585-593. PubMed ID: 30933582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare's Hospital Readmission Reduction Program reduced fall-related health care use: An unexpected benefit?
    Hoffman GJ; Alexander NB; Ha J; Nguyen T; Min LC
    Health Serv Res; 2024 Feb; 59(1):e14246. PubMed ID: 37806664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-demographic and -economic factors associated with 30-day readmission for conditions targeted by the hospital readmissions reduction program: a population-based study.
    Murray F; Allen M; Clark CM; Daly CJ; Jacobs DM
    BMC Public Health; 2021 Oct; 21(1):1922. PubMed ID: 34688255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further Evidence on the System-Wide Effects of the Hospital Readmissions Reduction Program.
    Demiralp B; He F; Koenig L
    Health Serv Res; 2018 Jun; 53(3):1478-1497. PubMed ID: 28480598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of the Hospital Readmissions Reduction Program across Insurance Types in California.
    Zingmond DS; Liang LJ; Parikh P; Escarce JJ
    Health Serv Res; 2018 Dec; 53(6):4403-4415. PubMed ID: 29740816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia.
    Khera R; Dharmarajan K; Wang Y; Lin Z; Bernheim SM; Wang Y; Normand ST; Krumholz HM
    JAMA Netw Open; 2018 Sep; 1(5):e182777. PubMed ID: 30646181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Hospital Readmissions Reduction Program Policy on 30-Day and 90-Day Readmissions in Patients With Acute Myocardial Infarction: A 10-Year Trend From the National Readmissions Database.
    Sana MK; Kumi D; Park DY; Asemota IR; DeAngelo S; Yilmaz M; Hammo H; Shaka H; Vij A
    Curr Probl Cardiol; 2023 Jul; 48(7):101696. PubMed ID: 36921652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act.
    Angraal S; Khera R; Zhou S; Wang Y; Lin Z; Dharmarajan K; Desai NR; Bernheim SM; Drye EE; Nasir K; Horwitz LI; Krumholz HM
    Am J Med; 2018 Nov; 131(11):1324-1331.e14. PubMed ID: 30016636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the Medicare hospital readmissions reduction program on vulnerable populations.
    Gai Y; Pachamanova D
    BMC Health Serv Res; 2019 Nov; 19(1):837. PubMed ID: 31727168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Hospital Readmissions From the Emergency Department After Implementation of Medicare's Hospital Readmissions Reduction Program.
    Hsuan C; Carr BG; Hsia RY; Hoffman GJ
    JAMA Netw Open; 2020 May; 3(5):e203857. PubMed ID: 32356883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.
    Puebla Neira DA; Hsu ES; Kuo YF; Ottenbacher KJ; Sharma G
    Am J Respir Crit Care Med; 2021 Feb; 203(4):437-446. PubMed ID: 32871097
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes to Racial Disparities in Readmission Rates After Medicare's Hospital Readmissions Reduction Program Within Safety-Net and Non-Safety-Net Hospitals.
    Chaiyachati KH; Qi M; Werner RM
    JAMA Netw Open; 2018 Nov; 1(7):e184154. PubMed ID: 30646342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis.
    Wadhera RK; Joynt Maddox KE; Kazi DS; Shen C; Yeh RW
    BMJ; 2019 Aug; 366():l4563. PubMed ID: 31405902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions.
    Desai NR; Ross JS; Kwon JY; Herrin J; Dharmarajan K; Bernheim SM; Krumholz HM; Horwitz LI
    JAMA; 2016 Dec; 316(24):2647-2656. PubMed ID: 28027367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.